http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018200510-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c47cfaf674c99c58764f9708d2e0f416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6ee312f3c77c7ad2bf5458c7a6567b7
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36002
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-327
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-20
filingDate 2018-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a02b9ebe88f8f784cdd592099365d11b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e049956cd2983ee58cd7efb2165c6b3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2563514184400d4a766f03b73449442c
publicationDate 2018-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2018200510-A1
titleOfInvention Nanosecond pulsed electric fields cause melanomas to self-destruct
abstract Methods for a new, drug-free therapy for treating solid skin tumors through the application of nanosecond pulsed electric fields (“nsPEFs”) are provided. In one embodiment of the invention, the cells are melanoma cells, and the applied nsPEFs penetrate into the interior of tumor cells and cause tumor cell nuclei to rapidly shrink and tumor blood flow to stop. This new technique provides a highly localized targeting of tumor cells with only minor effects on overlying skin.
priorityDate 2006-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6326177-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005288730-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002010491-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8048067-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86591708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6331297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453947315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57417070
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451431471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507060
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405512
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01382
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394204
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID320930

Total number of triples: 41.